Inhaled nitric oxide and oral nifedipine in a preterm infant with bronchopulmonary dysplasia and pulmonary hypertension

Author： Rosati Enrico   Butera Gianfranco   Bossone Eduardo   Felice Claudio   Latini Giuseppe  

Publisher： Springer Publishing Company

ISSN： 0340-6199

Source： European Journal of Pediatrics, Vol.166, Iss.7, 2007-07, pp. : 737-738

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Biochemical Screening for Pulmonary Hypertension in Preterm Infants with Bronchopulmonary Dysplasia

By  

Neonatology, Vol. 109, Iss. 3, 2016-01 ,pp. : 190-194

Karger

Access to resources Recommend Favorite

Long-Term Outcomes of Pulmonary Hypertension in Preterm Infants with Bronchopulmonary Dysplasia

By  

Neonatology, Vol. 110, Iss. 3, 2016-05 ,pp. : 181-189

Karger

Access to resources Recommend Favorite

Risk Factors for Pulmonary Artery Hypertension in Preterm Infants with Moderate or Severe Bronchopulmonary Dysplasia

By  

Neonatology, Vol. 101, Iss. 1, 2011-07 ,pp. : 40-46

Karger

Access to resources Recommend Favorite

Serial Changes of Serum Endostatin and Angiopoietin-1 Levels in Preterm Infants with Severe Bronchopulmonary Dysplasia and Subsequent Pulmonary Artery Hypertension

By  

Neonatology, Vol. 106, Iss. 1, 2014-05 ,pp. : 55-61

Karger

Access to resources Recommend Favorite

Effect of Inhaled Nitric Oxide in Endothelin-1-Induced Pulmonary Hypertension

By  

Neonatology, Vol. 73, Iss. 4, 1998-03 ,pp. : 246-253

Karger

Access to resources Recommend Favorite